|
Report Date : |
06.06.2013 |
IDENTIFICATION DETAILS
|
Name : |
DALAS BIOTECH LIMITED |
|
|
|
|
Registered
Office : |
E-292, RIICO Industrial Area, Bhiwadi – 301019, Rajasthan |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Date of
Incorporation : |
18.07.1989 |
|
|
|
|
Com. Reg. No.: |
005056 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.44.780 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24232RJ1989PLC005056 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
JPRD02357F |
|
|
|
|
PAN No.: [Permanent Account No.] |
AACCS4061Q |
|
|
|
|
Legal Form : |
Closely Held Public Limited Liability Company. |
|
|
|
|
Line of Business
: |
Manufacturer of Medicines Intermediates. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B (32) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 1012200 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having a moderate track record. It has incurred loss from its operations during 2012. However, trade relations are reported as fair. Business is active.
Payment terms are slow but correct. The company can be considered normal for business dealings with some
caution. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
Long Term: B+ |
|
Rating Explanation |
High Risk of default |
|
Date |
04.07.2012 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
LOCATIONS
|
Registered Office/Factory : |
E-292, RIICO Industrial Area, Bhiwadi – 301019, Rajasthan, India |
|
Tel. No.: |
91-1493-222527/222123/223478 |
|
Fax No.: |
91-1493-222547 |
|
Email: |
|
|
Website : |
|
|
|
|
|
Branches: |
DELHI LONDON |
DIRECTORS
AS ON 29.09.2012
|
Name : |
Mr. Anil Kumar Rajani |
|
Designation : |
Director |
|
Address : |
D-34, Gulmohar Park, 2nd Floor, New Delhi , India |
|
Date of Appointment : |
15.05.1998 |
|
DIN No.: |
01965248 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U63010DL1997PTC090907 |
FAST TRACK MOVEMENTS
PRIVATE LIMITED |
Director |
27/11/1997 |
27/11/1997 |
- |
Strike off |
NO |
|
2 |
U24232RJ1989PLC005056 |
DALAS BIOTECH
LIMITED |
Managing
director |
01/04/2010 |
15/05/1998 |
- |
Active |
NO |
|
Name : |
Mr. Atul Rajani |
|
Designation : |
Director |
|
Address : |
D-34, Gulmohar Park, 2nd Floor, New Delhi , India |
|
Date of Appointment : |
26.11.2001 |
|
DIN No.: |
02664208 |
|
Name : |
Ms. Lekha Rajani |
|
Designation : |
Director |
|
Address : |
D-34, Gulmohar Park, 2nd Floor, New Delhi , India |
|
Date of Appointment : |
31.05.2006 |
|
DIN No.: |
02654340 |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 29.09.2012
|
Names of Shareholders |
|
No. of Shares |
|
Babi Investment Limited |
|
35000 |
|
Anil Kumar Rajani |
|
297329 |
|
Manish Sharma |
|
10 |
|
C S Beri |
|
10 |
|
Asha Yogi |
|
10 |
|
Arjun Dass Lund |
|
10 |
|
Deepika Rajani |
|
53302 |
|
Sangeeta Rajani |
|
49668 |
|
P C Yogi |
|
10 |
|
Lekha Rajani |
|
12042 |
|
Atul Rajani |
|
413 |
|
Total |
|
447804 |
AS ON 29.09.2012
|
Category |
Percentage |
|
Bodies corporate |
7.82 |
|
Directors or relatives of Directors |
92.18 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Medicines Intermediates. |
||||
|
|
|
||||
|
Products : |
|
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Bankers : |
Oriental Bank of Commerce, M1/2/3, Connaught Circus, New Delhi –
110001, Delhi, India |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Facilities : |
Nature of Security of
Short Term Borrowings; #A Working Capital Loan from
Banks are secured by way of equitable mortgage of the land and building at
plot no. E-292, RIICO Industrial Area and hypothecation of Plant and
machinery and hypothecation of stock and debts of the company and also
guaranted personally by the directors.
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
S. Singhal and Company Chartered Accountant |
|
Address : |
E-127, Industrial Area, Bhiwadi – 301019, Rajasthan, India |
|
|
|
|
Associates/Subsidiaries : |
Nil |
CAPITAL STRUCTURE
AS ON 31.03.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
900000 |
Equity Shares |
Rs.100/- each |
Rs. 90.000 Millions |
|
100000 |
10% Non Cumulative redeemable Preference Shares |
Rs.100/- each |
Rs. 10.000 Millions |
|
|
Total |
|
Rs. 100.000
Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
447804 |
Equity Shares |
Rs.100/-
each |
Rs.44.780
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
44.780 |
34.279 |
42.458 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
208.270 |
99.289 |
82.759 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
253.050 |
133.568 |
125.217 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
333.431 |
209.484 |
74.630 |
|
|
2] Unsecured Loans |
0.004 |
141.305 |
141.797 |
|
|
TOTAL BORROWING |
333.435 |
350.789 |
216.427 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
17.618 |
|
|
|
|
|
|
|
|
TOTAL |
586.485 |
484.357 |
359.262 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
390.765 |
353.269 |
229.880 |
|
|
Capital work-in-progress |
30.880 |
4.280 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
3.976 |
(19.950) |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
112.003
|
150.096
|
49.416 |
|
|
Sundry Debtors |
186.444
|
249.337
|
185.087 |
|
|
Cash & Bank Balances |
24.122
|
27.923
|
44.439 |
|
|
Other Current Assets |
0.360
|
2.968
|
0.000 |
|
|
Loans & Advances |
55.202
|
71.243
|
40.426 |
|
Total
Current Assets |
378.131
|
501.567
|
319.368 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
149.491
|
262.901
|
125.638 |
|
|
Other Current Liabilities |
62.139
|
84.719
|
51.643 |
|
|
Provisions |
5.637
|
7.189
|
12.705 |
|
Total
Current Liabilities |
217.267
|
354.809
|
189.986 |
|
|
Net Current Assets |
160.864
|
146.758
|
129.382 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
586.485 |
484.357 |
359.262 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
775.425 |
868.971 |
773.421 |
|
|
|
Other Income |
7.340 |
2.817 |
4.104 |
|
|
|
TOTAL (A) |
782.765 |
871.788 |
777.525 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Material |
667.374 |
745.472 |
591.803 |
|
|
|
Diff in Excise Duty on Clo.& Op Stock of FG |
0.000 |
0.000 |
(0.955) |
|
|
|
Manufacturing Expenses |
0.000 |
0.000 |
58.852 |
|
|
|
Employee Expenses |
38.001 |
40.574 |
|
|
|
|
Payment to & Provisions for Employees |
0.000 |
0.000 |
21.230 |
|
|
|
Administrative Expenses |
0.000 |
0.000 |
15.505 |
|
|
|
Selling & Distribution exp. |
0.000 |
0.000 |
13.528 |
|
|
|
Increase ( Decrease ) in stock |
18.066 |
(49.645) |
12.552 |
|
|
|
Other Expenses |
72.365 |
84.917 |
0.000 |
|
|
|
TOTAL (B) |
795.806 |
821.318 |
712.515 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
(13.041) |
50.470 |
65.010 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
48.500 |
23.283 |
12.166 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
(61.541) |
27.187 |
52.844 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
19.325 |
13.394 |
9.860 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
(80.866) |
13.793 |
42.984 |
|
|
|
|
|
|
|
|
|
Less |
TAX (I) |
(23.924) |
5.445 |
17.297 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-I) (J) |
(56.942) |
8.350 |
25.687 |
|
|
Less/ Add |
MAT Credit
Availed |
0.000 |
0.000 |
3.386 |
|
|
Less/ Add |
Provision of Tax
(Short created in Earlier Years) |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
NA |
NA |
25.162 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
NA |
NA |
54.235 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
40.387 |
296.998 |
169.951 |
|
|
TOTAL EARNINGS |
40.387 |
296.998 |
169.951 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
351.966 |
276.403 |
208.235 |
|
|
TOTAL IMPORTS |
351.966 |
276.403 |
208.235 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
(163.32) |
24.73 |
76.00 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
PAT / Total Income |
(%) |
(7.27)
|
0.95
|
3.30 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
(10.43)
|
1.58
|
5.55 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
(10.52)
|
1.61
|
7.82 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
(0.32)
|
0.10
|
0.34 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
1.32
|
2.62
|
3.24 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.74
|
1.49
|
1.68 |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in Report
(Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-------- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
No |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
---------------------- |
|
22] |
Litigations that the firm
/ promoter involved in |
---------------------- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
---------------------- |
|
26] |
Buyer visit details |
No |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
Yes |
REDEMPTION OF PREFERENCE SHARES CAPITAL AND
ISSUE OF SHARES
The Company has achieved a
'turn-over of Rs.775.425 Millions as compared to turnover of Rs.8687.000
Millions during the corresponding last year, due to sluggish market conditions which impacted ail the players of
the Pharmaceutical industry.
The Company's performance
was also impacted by scheduled over run of expansion project of Unit 1. The
delay in project is attributed to the fact that the project expansion was, going on alongside with normal
production at the plant. The expansion at Unit I is now
complete.
The finance cost, of the Company
also increased considerably in the current
year, due to increased borrowing of the Company to finance the expansion plans
of the company. This has lead to loss from the ordinary business activities of the
Company during the current financial year of the Company.
The Company did expansion
by adding new plant to manufacture cefpodoxime proxetil. The product at
production environment caused/expected. Due to low yield and lower than
expected prices the production of this product become uneconomical and they
decided to shut down production of this product.
The sale price of the
flagship product Cefixime also reduced considerably whereas the cost of raw
remained higher than the past average price. This resulted into depletion of
margin. The Company has successfully launched, new Product, Amoxicillin, via
enzymatic route to overcome the aforesaid situation. This product has been well received
in the market, the margin is positive end
in current year they expect to
back to profit. The Company has focused on developing new products during the
year under review which will increase the
turnover and operating
margins of t h e Company in the coming years.
CHARGES
|
ENTITY |
PERSON |
COMPETENT
AUTHORITY |
REGULATORY
CHARGES |
REGULATORY
ACTION(S) / DATE OF ORDER |
FURTHER
DEVELOPMENTS |
|
DALAS BIOTECH LTD. |
VIKRAM
SETH |
CBEC |
DEFAULTED IN PAYMENT OF CUSTOMS/EXCISE DUTIES |
NOTICE ISSUED UNDER SECTION 142 OF CUSTOMS ACT, 1962 |
|
Fixed Assets
·
Land
·
Building
·
Plant and Machinery
·
Furniture & Fixture
·
Mis. Fixed Assets
·
Lab Equipments
·
Computer
·
Office Equipment
·
Vehicle
Form 8
|
Corporate identity number of the company |
U24232RJ1989PLC005056 |
|
Name of the company |
DALAS BIOTECH
LIMITED |
|
Address of the registered office or of the
principal place of business in |
E-292, RIICO
Industrial Area, Bhiwadi – 301019, Rajasthan, India |
|
This form is for |
Modification of charge |
|
Type of charge |
Immovable Property |
|
Particular of charge holder |
Oriental Bank of
Commerce, M1/2/3, Connaught Circus, New Delhi – 110001, Delhi, India Email - delhiroc@jksco.in |
|
Nature of instrument creating charge |
Letter Evidencing Deposit of Title Deeds
For Creation of Equitable Mortgage (LTR-21) |
|
Date of instrument Creating the charge |
01.02.2012 |
|
Amount secured by the charge |
Rs. 37.500 Millions |
|
Brief of the principal terms an conditions
and extent and operation of the charge |
Rate of Interest As per sanction terms Terms of Repayment As per sanction terms Margin As per sanction terms Extent and Operation of the charge The company's immovable properties as
mentioned hereunder (as per Column no. 15) are mortgaged to collaterally secure
the Term Loan of Rs. 37.500 Millions granted
by the bank to the borrower Others The modification of charge for Limit
aggregating to Rs. 475.000 millions (Consisting of CC, BG, TL & LC) and
Term Loan III of Rs. 45.000 millions has been filed separately at their
Charge ID 10172622 and 10241193 respectively |
|
Short particulars of the property charged |
Equitable mortgage by deposit of title
deeds of immovable properties situated at Plot No. SPA-501 A,Phase-1, RIICO
Industrial Area,Bhiwadi, District,Alwar |
|
Date of instrument modifying the charge |
24.09.2011 |
|
Particulars of the present modification |
The Term Loan of Rs.37.500 millions shall
now also be collaterally secured by equitable mortgage by deposit of title deeds
of immovable properties situated at Plot No. SPA-501 A,Phase-I,RIICO
Industrial Area, Bhiwadi,District Alwar |
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international anti-terrorism
laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited pyments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record exists
to suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.56.42 |
|
|
1 |
Rs.86.54 |
|
Euro |
1 |
Rs.73.86 |
INFORMATION DETAILS
|
Information
Gathered by : |
-- |
|
|
|
|
Report Prepared
by : |
SDA |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
4 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
2 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
4 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
32 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.